Abstract
Purpose
This study was conducted in order to characterize the prevalence of falls and functional impairments (FIs) and their association with chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors.
Methods
We analyzed baseline assessments from a phase III RCT in cancer survivors with self-reported CIPN scores of >4 out of 10. Patients completed the EORTC QLQ-CIPN-20 for neuropathy and reported falls in the previous 3 months. FIs were defined using the Activities of Daily Living subsection of the Vulnerable Elder’s Scale. Associations of baseline characteristics and CIPN with falls and FIs were examined using logistic regression.
Results
Of 421 patients, 11.9 % experienced recent falls and 26.6 % reported FIs. Motor neuropathy was the only factor associated with falls (OR = 1.127, p = 0.01). Factors associated with FIs included non-white race (OR = 0.335 white relative to non-white, 0.781, p = 0.01) and greater motor neuropathy scores (OR = 1.262, p < 0.0001).
Conclusion
CIPN, primarily motor, is associated with falls and FIs. Future prospective research should investigate the ability of motor neuropathy severity to predict falls.
Similar content being viewed by others
References
Ocean AJ, Vahdat LT (2004) Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer 12(9):619–625. doi:10.1007/s00520-004-0657-7
Argyriou AA, Koltzenburg M, Polychronopoulos P, Papapetropoulos S, Kalofonos HP (2008) Peripheral nerve damage associated with administration of taxanes in patients with cancer. Crit Rev Oncol Hematol 66(3):218–228. doi:10.1016/j.critrevonc.2008.01.008
Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR (2004) Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109(1–2):132–142. doi:10.1016/j.pain.2004.01.021
Quasthoff S, Hartung HP (2002) Chemotherapy-induced peripheral neuropathy. J Neurol 249(1):9–17
Windebank AJ, Grisold W (2008) Chemotherapy-induced neuropathy. J Peripher Nerv Syst 13(1):27–46. doi:10.1111/j.1529-8027.2008.00156.x
Tofthagen C, Overcash J, Kip K (2012) Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Canc 20(3):583–589. doi:10.1007/s00520-011-1127-7
Mohile SG, Fan L, Reeve E, Jean-Pierre P, Mustian K, Peppone L, Janelsins M, Morrow G, Hall W, Dale W (2011) Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol 29(11):1458–1464. doi:10.1200/JCO.2010.31.6695
Mohile SG, Xian Y, Dale W, Fisher SG, Rodin M, Morrow GR, Neugut A, Hall W (2009) Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Canc Inst 101(17):1206–1215. doi:10.1093/jnci/djp239
Lisa Sprod SGM, Lin Fan, Michelle Christine Janelsins, Luke Joseph Peppone, Kavita Dayal Chandwani, Gary R. Morrow, Karen Michelle Mustian (2012) Physical activity participation and functional limitations in geriatric cancer survivors. J Clin Oncol (suppl; abstr 9009)
Bylow K, Dale W, Mustian K, Stadler WM, Rodin M, Hall W, Lachs M, Mohile SG (2008) Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy. Urology 72(2):422–427. doi:10.1016/j.urology.2008.03.032
Masud T, Morris RO (2001) Epidemiology of falls. Age Ageing 30(Suppl 4):3–7
Stone C, Lawlor PG, Nolan B, Kenny RA (2011) A prospective study of the incidence of falls in patients with advanced cancer. J Pain Symptom Manag 42(4):535–540. doi:10.1016/j.jpainsymman.2011.01.006
Stone CA, Lawlor PG, Savva GM, Bennett K, Kenny RA (2012) Prospective study of falls and risk factors for falls in adults with advanced cancer. J Clin Oncol 30(17):2128–2133. doi:10.1200/JCO.2011.40.7791
Saliba D, Elliott M, Rubenstein LZ, Solomon DH, Young RT, Kamberg CJ, Roth C, MacLean CH, Shekelle PG, Sloss EM, Wenger NS (2001) The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 49(12):1691–1699
Mohile SG, Bylow K, Dale W, Dignam J, Martin K, Petrylak DP, Stadler WM, Rodin M (2007) A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 109(4):802–810. doi:10.1002/cncr.22495
Luciani A, Ascione G, Bertuzzi C, Marussi D, Codeca C, Di Maria G, Caldiera SE, Floriani I, Zonato S, Ferrari D, Foa P (2010) Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol 28(12):2046–2050. doi:10.1200/JCO.2009.25.9978
Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lanteri-Minet M, Grant R, Huddart R, Moynihan C, Maher J, Lucey R (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41(8):1135–1139. doi:10.1016/j.ejca.2005.02.012
Cavaletti G, Cornblath DR, Merkies IS, Postma TJ, Rossi E, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galie E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG (2013) The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol 24(2):454–462. doi:10.1093/annonc/mds329
Barton DL, Wos EJ, Qin R, Mattar BI, Green NB, Lanier KS, Bearden JD 3rd, Kugler JW, Hoff KL, Reddy PS, Rowland KM Jr, Riepl M, Christensen B, Loprinzi CL (2011) A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Canc 19(6):833–841. doi:10.1007/s00520-010-0911-0
Harrison T (2009) Health disparities among Latinas aging with disabilities. Fam Community Health 32(1 Suppl):S36–S45. doi:10.1097/01.FCH.0000342838.05607.63
Zsembik BA, Peek MK, Peek CW (2000) Race and ethnic variation in the disablement process. J Aging Health 12(2):229–249
SEER Cancer Statistics. (2011) National Cancer Institute. http://seer.cancer.gov/statfacts/html/all.html. Accessed Jan 2012
Balducci L (2005) Epidemiology of cancer and aging. J Oncol Manag 14(2):47–50
Wehren LE (2003) The epidemiology of osteoporosis and fractures in geriatric medicine. Clin Geriatr Med 19(2):245–258
Vellas BJ, Wayne SJ, Romero LJ, Baumgartner RN, Garry PJ (1997) Fear of falling and restriction of mobility in elderly fallers. Age Ageing 26(3):189–193
Prevention CfDCa (2010) Falls among older adults: an overview. http://www.cdc.gov/HomeandRecreationalSafety/Falls/adultfalls.html. Accessed Jan 2012
Chan BK, Marshall LM, Winters KM, Faulkner KA, Schwartz AV, Orwoll ES (2007) Incident fall risk and physical activity and physical performance among older men: the Osteoporotic Fractures in Men Study. Am J Epidemiol 165(6):696–703. doi:10.1093/aje/kwk050
Erlandson KM, Allshouse AA, Jankowski CM, Duong S, MaWhinney S, Kohrt WM, Campbell TB (2012) Risk factors for falls in HIV-infected persons. J Acquir Immune Defic Syndr 61(4):484–489. doi:10.1097/QAI.0b013e3182716e38
Patel S, Hyer S, Tweed K, Kerry S, Allan K, Rodin A, Barron J (2008) Risk factors for fractures and falls in older women with type 2 diabetes mellitus. Calcif Tissue Int 82(2):87–91. doi:10.1007/s00223-007-9082-5
Richardson JK, Ching C, Hurvitz EA (1992) The relationship between electromyographically documented peripheral neuropathy and falls. J Am Geriatr Soc 40(10):1008–1012
Oka N, Sugiyama H, Kawasaki T, Mizutani K, Matsui M (2005) Falls in peripheral neuropathy. Rinsho Shinkeigaku 45(3):207–210
Stauder R, Moser K, Holzner B, Sperner-Unterweger B, Kemmler G (2010) Six independent domains are defined by geriatric assessment in elderly cancer patients. Crit Rev Oncol Hematol 74(2):97–105. doi:10.1016/j.critrevonc.2009.04.010
Pasetto LM, D'Andrea MR, Rossi E, Monfardini S (2006) Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol Hematol 59(2):159–168. doi:10.1016/j.critrevonc.2006.01.001
Acknowledgments
This work was funded by the National Cancer Institute (R25CA10618 and U10CA37420). The work was also funded by a generous gift from Sandy Lloyd to the Geriatric Oncology Program at the James Wilmot Cancer Center. The study sponsors had no role in the study design, data collection, or data interpretation. We thank the patients, clinicians, and researchers of the University of Rochester Community Clinical Oncology Program who contributed to this study.
Conflict of interest
The authors have no conflicts of interest to disclose. We have full control of all primary data and agree to allow the journal to review the data if requested.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 28 kb)
Rights and permissions
About this article
Cite this article
Gewandter, J.S., Fan, L., Magnuson, A. et al. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer 21, 2059–2066 (2013). https://doi.org/10.1007/s00520-013-1766-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-013-1766-y